Gastroenterology
Conference Coverage
Elective CRC resections increase with universal insurance
Expanding access to health insurance for low- and moderate-income families has apparently improved colorectal cancer care in Massachusetts, and...
News
No HPV DNA detected in esophageal cancer tumors
Australian researchers who analyzed 233 esophageal adenocarcinoma tumor specimens found no evidence of human papillomavirus DNA.
News
Labeled peptide bound the claudin-1 target in colorectal cancer models
An optically labeled peptide rapidly and specifically bound the claudin-1 membrane protein, a “promising” target for early detection of human...
News
Study backed familial component of advanced adenoma risk
Siblings of patients with advanced adenoma had sixfold higher odds of having the tumors themselves, as compared with controls, said the authors of...
News
Thrombocytopenia signals multiorgan system failure in acute liver failure
Key clinical point: In patients with acute liver failure (ALF), decreasing platelet counts were associated with systemic inflammation and greater...
Conference Coverage
TAMIS for rectal cancer holds its own vs. TEM
Transanal minimally invasive surgery for removal of rectal tumors achieved equal outcomes to transanal endoscopic microsurgery with measurable...
News
Muscle loss during chemotherapy predicts poor survival in metastatic colorectal cancer
Key clinical point: Patients with metastatic colorectal cancer (mCRC) whose muscle mass dropped by 9% or more during chemotherapy had...
News
SIRT plus FOLFOX chemo for mCRC improved progression-free survival in liver only
Key clinical point: Selective internal radiation therapy (SIRT) combined with FOLFOX-based chemotherapy in patients with metastatic colorectal...
New Therapies
New therapies bring hope after much frustration
News
Neurotoxicity tempers case for oxaliplatin in older adults with colorectal cancer
Key clinical point: The high rate of oxaliplatin-induced neurotoxicity in older adults should be considered when making treatment decisions. Major...
News
Common medications linked to better survival in pancreatic cancer
Key clinical point: Use of certain common medications is associated with better survival in patients with pancreatic cancer. Major finding: Risk...